CanadaBuys #AB-2026-04449

University of Calgary seeks clonoSEQ MRD assay materials and processing services for Multiple Myeloma research

The University of Calgary CTRC Lab is seeking to procure specialized assay materials and processing services for minimal residual disease (MRD) testing in Multiple Myeloma research. - Government Buyer: - University of Calgary, CTRC Lab - OEMs and Vendors: - Adaptive Biotechnologies Corporation (OEM and sole provider) - Products/Services Requested: - clonoSEQ MRD assay materials (no part numbers or quantities specified) - clonoSEQ MRD assay processing services (no part numbers or quantities specified) - Unique or Notable Requirements: - Only Adaptive Biotechnologies can provide the clonoSEQ MRD assay due to proprietary intellectual property, patents, and closed-source bioinformatics algorithms - The assay must deliver ultra-high sensitivity, detecting one malignant cell among one million healthy cells (10^-6 sensitivity) - No other supplier is authorized or capable of providing an equivalent solution

Description

The University of Calgary CTRC Lab is seeking to procure assay materials and processing services to support research involving minimal residual disease (MRD) testing in Multiple Myeloma. The objective is to contract a service provider capable of ultra-high sensitivity detection of one malignant cell among one million healthy cells. The procurement intends to purchase the clonoSEQ MRD assay materials and processing services exclusively from Adaptive Biotechnologies Corporation, as this assay uniquely meets the technical requirements and is protected by intellectual property rights. No other supplier is authorized or capable of providing an equivalent solution due to proprietary protections.

View original listing